Engineering virus-like particles as vaccine platforms.
Kathryn M. Frietze +2 more
semanticscholar +1 more source
Muscle-specific gene editing therapy via mammalian fusogen-directed virus-like particles. [PDF]
Zhou SK +11 more
europepmc +1 more source
Protection Against Toxoplasma gondii Lethal ME49 Challenge Induced by Influenza Virus-like Particles Containing Dense Granule Protein 14. [PDF]
Mao J +9 more
europepmc +1 more source
Customised virus-like particles: Opening a new chapter for clinical precision gene therapy. [PDF]
Zhu X, Zhang Q, Zhou X, Cai Y, Hong J.
europepmc +1 more source
Stabilization of norovirus GII.3 virus-like particles by rational disulfide engineering. [PDF]
Warren C +16 more
europepmc +1 more source
Virus-like Particles Formed by the Coat Protein of the Single-Stranded RNA Phage PQ465 as a Carrier for Antigen Presentation. [PDF]
Vasyagin EA, Mardanova ES, Ravin NV.
europepmc +1 more source
Chimeric virus-like particles carrying the CLEC17A carbohydrate-recognition domain significantly reduce Macrobrachium rosenbergii nodavirus infection in Sf9 cells. [PDF]
Chantunmapitak R +7 more
europepmc +1 more source
Systematic review and meta-analysis of the effectiveness of polypeptide, virus-like particles, and viral vector vaccines for foot-and-mouth disease (2020-2025). [PDF]
Elrashedy A +6 more
europepmc +1 more source
Virus-like Particles Carrying a Porcine Circovirus Type 2b Peptide Induce an Antibody Response and Reduce Viral Load in Immunized Pigs. [PDF]
Hernández-Aviña ADS +8 more
europepmc +1 more source
3C protease-independent production of foot-and-mouth disease virus-like particles in Pichia pastoris. [PDF]
Li Z +7 more
europepmc +1 more source

